Shilpa Medicare has received an approval to merge Raichem Life Sciences, a 100% subsidiary of the company with itself to have cost synergies and other operational benefits. The company has received an approval for merger at its board meeting held on August 11, 2011.
Recently, Shilpa Medicare had acquired controlling stake in Nu Therapeutics. Nu is established by the Technocarts for manufacturing of “Oral Fast Dissolving Thin Strip Dosage” jointly with others. It had filed several patents, technical designs/plans, concepts and expects to commence production shortly. In India it is one of few units of its kind.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: